Literature DB >> 27273354

Editorial: Frailty and Polypharmacy.

Y Rolland1, J E Morley.   

Abstract

Year:  2016        PMID： 27273354     DOI： 10.1007/s12603-015-0510-3

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  72 in total

1.  Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.

Authors:  Alexander Bennett; Danijela Gnjidic; Mark Gillett; Peter Carroll; Slade Matthews; Kristina Johnell; Johan Fastbom; Sarah Hilmer
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

2.  Characteristics of polymedicated (≥ 4) elderly: a survey in a community-dwelling population aged 60 years and over.

Authors:  N Husson; G Watfa; M-C Laurain; C Perret-Guillaume; J-Y Niemier; P Miget; A Benetos
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

3.  Frailty: successful clinical practice implementation.

Authors:  J-P Michel
Journal:  J Nutr Health Aging       Date:  2014-05       Impact factor: 4.075

4.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

5.  High-risk prescribing and incidence of frailty among older community-dwelling men.

Authors:  D Gnjidic; S N Hilmer; F M Blyth; V Naganathan; R G Cumming; D J Handelsman; A J McLachlan; D R Abernethy; E Banks; D G Le Couteur
Journal:  Clin Pharmacol Ther       Date:  2012-02-01       Impact factor: 6.875

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

7.  Relationship between anticholinergic drug use and one-year outcome among elderly people hospitalised in medical wards via emergency department: the SAFES cohort study.

Authors:  D Narbey; D Jolly; R Mahmoudi; T Trenque; F Blanchard; J-L Novella; M Dramé
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

8.  Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation.

Authors:  Jean Woo; Jason Leung; John E Morley
Journal:  J Am Geriatr Soc       Date:  2012-08-02       Impact factor: 5.562

9.  Looking for frailty in community-dwelling older persons: the Gérontopôle Frailty Screening Tool (GFST).

Authors:  B Vellas; L Balardy; S Gillette-Guyonnet; G Abellan Van Kan; A Ghisolfi-Marque; J Subra; S Bismuth; S Oustric; M Cesari
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

10.  Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people.

Authors:  Lilian L Peters; Han Boter; Erik Buskens; Joris P J Slaets
Journal:  J Am Med Dir Assoc       Date:  2012-05-12       Impact factor: 4.669
View more
  9 in total

1.  Editorial: Orthogeriatrics and Hip Fractures.

Authors:  A M Sanford; J E Morley; A McKee
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Editorial: Geriatrics in the 21st Century.

Authors:  B Vellas; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 3.  Frailty and sarcopenia in elderly.

Authors:  John E Morley
Journal:  Wien Klin Wochenschr       Date:  2016-09-26       Impact factor: 1.704

Review 4.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

5.  Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.

Authors:  Nemin Chen; Aniqa B Alam; Pamela L Lutsey; Richard F MacLehose; J'Neka S Claxton; Lin Y Chen; Alanna M Chamberlain; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2020-05-23       Impact factor: 5.501

6.  Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study.

Authors:  Diego Arauna; Alvaro Cerda; José Francisco García-García; Sergio Wehinger; Felipe Castro; Diego Méndez; Marcelo Alarcón; Eduardo Fuentes; Iván Palomo
Journal:  Clin Interv Aging       Date:  2020-06-29       Impact factor: 4.458

7.  Explaining the association between frailty and mortality in older adults: The mediating role of lifestyle, social, psychological, cognitive, and physical factors.

Authors:  Sascha de Breij; Judith J M Rijnhart; Noah A Schuster; M Liset Rietman; Mike J L Peters; Emiel O Hoogendijk
Journal:  Prev Med Rep       Date:  2021-10-07

8.  A pilot study to identify elderly patients with cognitive impairment for clinical pharmacist polypharmacy review in General Practice.

Authors:  Pamela Mills; Katie MacLure
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-26

9.  Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines.

Authors:  J G Ruiz; E Dent; J E Morley; R A Merchant; J Beilby; J Beard; C Tripathy; M Sorin; S Andrieu; I Aprahamian; H Arai; M Aubertin-Leheudre; J M Bauer; M Cesari; L-K Chen; A J Cruz-Jentoft; P De Souto Barreto; B Dong; L Ferrucci; R Fielding; L Flicker; J Lundy; J Y Reginster; L Rodriguez-Mañas; Y Rolland; A M Sanford; A J Sinclair; J Viña; D L Waters; C Won Won; J Woo; B Vellas
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 5.285
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.